Cargando…
Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge Study
BACKGROUND: Polymorbidity induces polypharmacy in older patients may lead to potential drug–drug interactions (DDI) which can modify the tolerance and safety of oncological treatments and alter the intended therapeutic effect. The objective of our study was to describe the decision-making process fo...
Autores principales: | Couderc, Anne-Laure, Boisseranc, Celia, Rey, Dominique, Nouguerede, Emilie, Greillier, Laurent, Barlesi, Fabrice, Duffaud, Florence, Deville, Jean-Laurent, Honoré, Stéphane, Villani, Patrick, Correard, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489933/ https://www.ncbi.nlm.nih.gov/pubmed/32982194 http://dx.doi.org/10.2147/CIA.S262209 |
Ejemplares similares
-
Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer Patients
por: Montegut, Coline, et al.
Publicado: (2021) -
Geriatric syndromes in a centenarians population
por: Croize-Pourcelet, Cécile, et al.
Publicado: (2022) -
Centenarians in nursing homes during the COVID-19 pandemic
por: Couderc, Anne-Laure, et al.
Publicado: (2021) -
Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer
por: Couderc, Anne-Laure, et al.
Publicado: (2022) -
Bevacizumab in the treatment of nonsquamous non-small cell lung
cancer: clinical trial evidence and experience
por: Greillier, Laurent, et al.
Publicado: (2016)